DAIHAN Scientific Co. Ltd (131220) — Cash Flow Quality Index
DAIHAN Scientific Co. Ltd (131220) has a Cash Flow Quality Index of 0.21x as of September 2025. Operating cash flow of ₩361.12 Million is below net income of ₩1.69 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 131220 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DAIHAN Scientific Co. Ltd Cash Flow Quality Index (2012–2024)
Historical Cash Flow Quality Index for DAIHAN Scientific Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check DAIHAN Scientific Co. Ltd (131220) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for DAIHAN Scientific Co. Ltd (2012–2024)
Year-by-year earnings quality comparison for DAIHAN Scientific Co. Ltd. For live market cap and the full company financial profile, see how much is DAIHAN Scientific Co. Ltd worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.02x | ₩3.99 Billion | ₩3.93 Billion | ▲ +10.7% |
| 2023 | 0.92x | ₩4.79 Billion | ₩5.22 Billion | ▼ -4.4% |
| 2022 | 0.96x | ₩4.51 Billion | ₩4.70 Billion | ▼ -12.5% |
| 2021 | 1.10x | ₩4.13 Billion | ₩3.77 Billion | ▼ -64.9% |
| 2020 | 3.13x | ₩5.35 Billion | ₩1.71 Billion | ▲ +57.3% |
| 2019 | 1.99x | ₩2.44 Billion | ₩1.23 Billion | ▼ -5.5% |
| 2018 | 2.10x | ₩3.76 Billion | ₩1.79 Billion | ▼ -53.3% |
| 2017 | 4.50x | ₩4.58 Billion | ₩1.02 Billion | ▲ +99.1% |
| 2016 | 2.26x | ₩4.12 Billion | ₩1.82 Billion | ▼ -23.5% |
| 2014 | 2.96x | ₩2.59 Billion | ₩875.88 Million | ▲ +553.5% |
| 2012 | 0.45x | ₩565.94 Million | ₩1.25 Billion | — |